• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jenburkt Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4394.0
  • ISIN : INE354A01013
1,011.70 -3 (-0.31%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    1,006.15

  • Today’s High

    1,039.80

  • Open

    1,015.00

  • Perv Close

    1,014.85

  • 52W Low

    683.40

  • 52W High

    1,375.00

Key Indicators

  • P/E(TTM)

    14.22

  • Mar.Cap (₹Cr.)

    446.49

  • Div & Yield %

    1.51

  • Book Value(₹)

    357.47

  • Debt-Equity Ratio

    -0.31

  • AGM Date

    28-Mar-2025

  • EPS

    71.16

  • P/E Ratio

    14.22

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    446.49

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.41

  • BV (₹)

    357.50

  • Sales( ₹ in Cr.)

    141.97

  • NP (in Cr.)

    25.93

  • NP Var(%)

    5.0

  • Div%

    153.0

  • CPS (₹)

    64.10

  • EPS (₹)

    58.80

  • Traded Value (₹ in Lakhs)

    446.49

  • 52 Week High

    1,375.00

  • 52 Week Low

    683.40

  • Price BSE

    1012.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    446.49

  • P/C Ratio

    15.80

  • P/E Ratio

    17.20

  • Price Vs.BV

    58.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 141.97 136.75 123.98 109.29 118.89 122.64
Excise Duty 141.63 136.14 123.73 108.87 118.04 122.05
Net Sales 141.97 136.75 123.98 109.29 118.89 122.64
Other Income 4.67 5.12 4.95 4.31 4.22 3.41
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 146.63 141.87 128.93 113.60 123.11 126.05
EXPENDITURE :
Raw Materials 141.63 136.14 123.73 108.87 118.04 122.05
Power & Fuel Cost 141.63 136.14 123.73 108.87 118.04 122.05
Employee Cost 42.49 38.81 36.49 32.38 36.51 31.20
Other Manufacturing Expenses 0.58 0.50 0.01 0.95 0.54 0.30
Selling & Administrative Expenses 31.04 29.03 24.32 23.03 25.46 28.10
Miscellaneous Expenses 0.58 0.50 0.01 0.95 0.54 0.30
Less : Pre-operative Expenses Capitalised :
Total Expenditure 111.46 109.01 99.06 91.96 101.97 99.42
Operating Profit 4.33 5.04 4.46 3.00 3.57 1.82
Interest 0.27 0.37 0.43 0.47 0.53 0.39
Gross Profit 35.18 32.86 29.87 21.64 21.14 26.63
Depreciation 2.34 2.26 1.90 2.04 2.30 1.35
Profit Before Tax 35.18 32.86 29.87 21.64 21.14 26.63
Tax 9.64 8.56 7.35 5.45 5.76 7.52
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.52 -0.23 0.30 -0.39 0.37 -0.31
Reported Net Profit 25.98 24.61 22.30 16.50 14.87 19.80
Extraordinary Items 35.18 32.86 29.87 21.64 21.14 26.63
Adjusted Net Profit 25.98 24.61 22.30 16.50 14.87 19.80
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 6.75 6.36 5.51 4.68 3.72 4.68
P & L Balance carried down 25.98 24.61 22.30 16.50 14.87 19.80
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 153.00 144.00 120.00 102.00 81.00 102.00
Dividend Per Share(Rs) 15.30 14.40 12.00 10.20 8.10 10.20
Earnings Per Share-Unit Curr 58.86 53.90 48.58 35.96 32.40 43.14
Book Value 6.75 6.36 5.51 4.68 3.72 4.68
Book Value(Adj)-Unit Curr 6.75 6.36 5.51 4.68 3.72 4.68

Shareholding Pattern

  • Promoter Group

    46.69%

  • Public Share Holding

    53.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 616,128 13.96 616,128 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,444,322 32.73 1,444,322 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,060,450 46.69 2,060,450 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,190 0.12 5,190 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,190 0.12 5,190 1
2] Non Institution
Bodies Corporate 133,564 3.03 132,964 51
Clearing Members 5,472 0.12 5,472 6
Directors of their Relatives 900 0.02 900 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 139,159 3.15 139,159 170
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 56,260 1.27 56,260 182
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 516,597 11.71 516,597 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,400,126 31.73 1,293,726 6,467
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 95,582 2.17 95,582 2
Sub Total 2,347,660 53.20 2,240,660 6,890
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,413,300 100.00 4,306,300 6,901

Company Background

Jenburkt Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Jenburkt Pharmaceuticals Ltd
  • BSE Code : 4394.0
  • ISIN : INE354A01013

  • Incorporation Year

    1985

  • Registered Office

    Nirmala Apartment P B No 37396
    93 Jayprakash Road Andheri(W), Mumbai,
    Maharashtra-400058

  • Telephone

    91-22-66943121/67603603

  • FAX

    91-22-66943127

  • Chairman

    Ashish U Bhuta

  • Managing Director

    Ashish U Bhuta

  • Company Secretary

    Ashish R Shah

  • Auditor

    D R Mehta & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Jenburkt Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jenburkt Pharma 1,011.70 146.63 141.97 14.22 25.67
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92